plentyofstocksFinancial Intelligence All briefings →
Insider Activity · SEC Form 4

Scribe Therapeutics, Inc. (SCTX) Insider Trading

Scribe Therapeutics, Inc. (Biological Products, (No Diagnostic Substances)) is on the radar because 5 different insiders have bought shares recently — $66.3M in aggregate. Cluster buys like this often signal management conviction the broader market hasn't priced in yet.

Buys: 5 · $66.34M Sales: 0 · —

Recent insider transactions

InsiderTypeSharesPriceValueDateSource
Avoro Ventures LLCDirector BUY 2,391,238 $15.16 $36.26M Jul 28, 2026 Form 4 →
GORDON CARL LDirector BUY 1,000,000 $15.00 $15.00M Jul 27, 2026 Form 4 →
OrbiMed Capital GP VIII LLCDirector BUY 1,000,000 $15.00 $15.00M Jul 27, 2026 Form 4 →
Lucas SvetlanaChief Business Officer BUY 3,000 $15.00 $45.0K Jul 23, 2026 Form 4 →
Parrot DavidChief Financial Officer BUY 2,666 $15.00 $40.0K Jul 23, 2026 Form 4 →

Recent SEC filings

FilingDateSource
8-KBylaws / Articles Amended Jul 27, 2026 Filing →
8-KScribe Therapeutics, Inc. Jul 27, 2026 Filing →

Insider trades, filings, and curated news for SCTX — updated daily.

Track SCTX on plentyofstocks →